Log in to search using one of your social media accounts:

 

Diabetes diet: Two tablespoons of this condiment before a meal can help lower blood sugar
TYPE 2 diabetes is a condition where the pancreas doesn ’t produce enough insulin or the body’s cells don’t react to insulin. If you already have it you may be able to prevent it developing by taking a particular condiment before a meal. (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2018 Category: Consumer Health News Source Type: news

Diabetic by HbA1c, Normal by OGTT Diabetic by HbA1c, Normal by OGTT
Population-based research found that individuals with normal glucose tolerance yet elevated HbA1c were not uncommon. What are the implications for the screening and diagnosis of type 2 diabetes?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 15, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Electronic modulation of carotid sinus nerve can be used as a treatment for type 2 diabetes in rats
(Diabetologia) The team lead by S í lvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 14, 2018 Category: International Medicine & Public Health Source Type: news

Semaglutide Bests Exenatide in Type 2 Diabetes Semaglutide Bests Exenatide in Type 2 Diabetes
Subcutaneous injection of semaglutide provides superior results to exenatide extended release (ER), also administered subcutaneously, in patients who have diabetes inadequately controlled by oral agents, according to findings from an open-label trial.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 12, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Type 2 Diabetes in Kids: Don't Miss It Type 2 Diabetes in Kids: Don't Miss It
Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 12, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Expert Interview Source Type: news

Gap in cardiovascular knowledge among diabetes patients
Well over a third of patients with type 2 diabetes say they do not fully understand their heightened risk of developing cardiovascular disease (CVD), according to a small survey by a pharmaceutical company. (Source: Nursing Times)
Source: Nursing Times - January 12, 2018 Category: Nursing Source Type: news

Diabetes is ‘storming the UK’ - Five ways to lower your risk of condition revealed
DIABETES cases have hit 4.3 million in the UK, including 500,000 people that don ’t even know they have the condition. Here’s five top tips to lower your risk of developing type 2 diabetes. (Source: Daily Express - Health)
Source: Daily Express - Health - January 12, 2018 Category: Consumer Health News Source Type: news

Type 1 and type 2 diabetes associated with negative outcomes in pregnancy
Both diabetes types are linked to adverse outcomes during pregnancy, such as stillbirths and Caesarean sections, a study inDiabetologia suggests.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 12, 2018 Category: Endocrinology Source Type: news

Dieting can help type 2 diabetes patients avoid insulin
Research inDiabetes, Obesity and Metabolism suggests that weight loss through lifestyle changes can significantly reduce the likelihood of type 2 diabetics needing insulin treatment.BBC (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 12, 2018 Category: Endocrinology Source Type: news

WellDoc, Voluntis to work together on combined offering for type 2 diabetes
Correction:  A previous version of this story mistated the projected timeline for the combined product. It is Q1 this year, not Q1 next year. WellDoc and Voluntis, two companies with FDA-cleared, clinically validated platforms aimed at the management of Type 2 diabetes, have signed a commercial agreement to co mbine their technologies and offer joint products in the future. (Source: mobihealthnews)
Source: mobihealthnews - January 11, 2018 Category: Information Technology Source Type: news

Diabetes: Diet and exercise lifestyle programme could revolutionise type 2 treatment
A CHEAP and simple 16-week NHS lifestyle programme concentrating on diet and exercise could revolutionise the treatment of type 2 diabetes, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - January 11, 2018 Category: Consumer Health News Source Type: news

BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
WILMINGTON, Del., Jan. 10, 2018 -- (Healthcare Sales & Marketing Network) -- AstraZeneca today announced that BYDUREON® BCise™ (exenatide extended-release) injectable suspension 2mg is now available in pharmacies across the United States. BYDUREON BCi... Biopharmaceuticals, Endocrinology, Product Launch AstraZeneca, BYDUREON BCise, exenatide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news

UnitedHealth Taps Into Emerging Mobile Diabetes Management
UnitedHealth Group has partnered with DexCom to launch a glucose management program using a wearable device to help older Americans manage their Type 2 diabetes via mobile technology. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 10, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NASDAQ:GOOGL NYSE:ANTM NASDAQ:DXCM Source Type: news

Diabetes: What happens if symptoms go undetected? Look for this to avoid dangerous outcome
TYPE 2 diabetes is the most common form of diabetes but signs and symptoms often develop gradually. But what happens if it is left untreated? (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2018 Category: Consumer Health News Source Type: news

New app motivates type 2 diabetes patients to be more active
(University of Utah Health) A research team led by scientists at University of Utah Health have developed an online interactive app to help motivate patients to be more physically activity to manage their disease. The results are published in the Jan. 9 issue of the Journal of Medical Internet Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2018 Category: International Medicine & Public Health Source Type: news

Side effects significantly reducing adherence to diabetes drugs
Many people with type 2 diabetes are not taking their medication due to unpleasant side effects including flatulence and diarrhoea, suggests a large-scale study, whose authors are urging doctors and nurses to actively ask their patients about medication adherence. (Source: Nursing Times)
Source: Nursing Times - January 9, 2018 Category: Nursing Source Type: news

New study debunks the common belief that Blacks have a higher diabetes risk than Whites – it all comes down to weight, for all of us
(Natural News) There’s a long-held belief that African Americans are more prone to developing type-2 diabetes; yet a new study has turned that idea in on its head. Researchers from Northwestern University have discovered that various modifiable, biological factors like body mass index (BMI) and blood pressure can predispose one to this condition, not genetics.... (Source: NaturalNews.com)
Source: NaturalNews.com - January 8, 2018 Category: Consumer Health News Source Type: news

Researchers have developed a novel skin patch for diabetics that encourages their bodies to produce more insulin
(Natural News) Millions of individuals with type 2 diabetes must remain vigilant when it comes to their blood sugar levels because this is a key component used to measure their health. Their glucose levels are often measured via blood sugar test kits, which involve pricking the finger to get a blood sample for testing. But... (Source: NaturalNews.com)
Source: NaturalNews.com - January 8, 2018 Category: Consumer Health News Source Type: news

Medical Under The Microscope
Having spent the majority of his career in academia, it is unsurprising that Juan Ochoa has brought scientific rigour and analysis to his role as Chief Medical Officer at Nestle Health Science. He focuses on commercialising concepts that originate in the laboratory by developing value propositions based on clinical and real-world evidence.The former trauma surgeon tells eyeforpharma that the value of a company and the solutions that they bring are ultimately determined by their capacityto solve unmet needs for the end consumer. According to Ochoa, there are several targets in healthcare – the patient, the physician, ...
Source: EyeForPharma - January 5, 2018 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news

Medical Under The Microscope
Having spent the majority of his career in academia, it is unsurprising that Juan Ochoa has brought scientific rigour and analysis to his role as Chief Medical Officer at Nestle Health Science. He focuses on commercialising concepts that originate in the laboratory by developing value propositions based on clinical and real-world evidence.The former trauma surgeon tells eyeforpharma that the value of a company and the solutions that they bring are ultimately determined by their capacityto solve unmet needs for the end consumer. According to Ochoa, there are several targets in healthcare – the patient, the physician, ...
Source: EyeForPharma - January 5, 2018 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news

Crystal structure of glucagon receptor key for type 2 diabetes drug development
According to research published inNature, scientists have determined the crystal structure of the human glucagon receptor, which may open doors to the discovery of new type 2 diabetes drugs.Phys.org (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 5, 2018 Category: Endocrinology Source Type: news

TOO TOXIC to swallow: Up to a third of diabetics don't take their pills because of the debilitating side effects
(Natural News) According to a group of researchers, at least a third of diabetics do not take their medication due to fear of possible side effects. Diabetics in the U.K. are often prescribed metformin, the most commonly prescribed drug for type 2 diabetes. While there is no definite data on how many of the 3.4 million... (Source: NaturalNews.com)
Source: NaturalNews.com - January 5, 2018 Category: Consumer Health News Source Type: news

Prevalence of Primary Aldosteronism Among Patients With T2D Prevalence of Primary Aldosteronism Among Patients With T2D
How common is primary aldosteronism in patients with type 2 diabetes?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Uncovering new digital solutions for type 2 diabetes
(Source: mobihealthnews)
Source: mobihealthnews - January 4, 2018 Category: Information Technology Source Type: news

Positive outcomes from WellDoc's BlueStar translate to cost savings, analysis finds
An analysis contracted by WellDoc found that the company ’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month. (Source: mobihealthnews)
Source: mobihealthnews - January 4, 2018 Category: Information Technology Source Type: news

Goodbye, Needles? Patch Might Be the Future for Blood-Sugar Tracking
THURSDAY, Jan. 4, 2018 -- Developers of a new patch hope to eliminate a big barrier in type 2 diabetes treatment -- painful finger-sticks and injections. The new patch -- which actually uses an array of tiny needles that researchers promise are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 4, 2018 Category: General Medicine Source Type: news

Quiz: How at risk are you of diabetes? Prevent signs and symptoms by taking this test
DIABETES can develop at any age, and type 2 diabetes is the most common form. So how at risk are you? Take the test to find out. (Source: Daily Express - Health)
Source: Daily Express - Health - January 4, 2018 Category: Consumer Health News Source Type: news

Putting Medical Under The Microscope
Having spent the majority of his career in academia, it is unsurprising that Juan Ochoa has brought scientific rigour and analysis to his role as Chief Medical Officer at Nestle Health Science. He focuses on commercialising concepts that originate in the laboratory benches by developing value propositions based on clinical and real-world evidence.The former trauma surgeon tells eyeforpharma that the value of a company and the solutions that they bring are ultimately determined by their capacity to solve unmet needs for the end consumer. According to Ochoa, there are several targets in healthcare – the patient, the ph...
Source: EyeForPharma - January 3, 2018 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news

A New Form of This Miracle Nutrient Is 8 Times More Powerful …
CoQ10 has made the mainstream. You can find it everywhere. But the type of CoQ10 I want to tell you about has been completely ignored. That’s too bad, because this new form is 8 times better at getting into your blood and staying there. And that’s where it has its miracle-like anti-aging effects. This new form of CoQ10 may give you the opportunity to live disease-free for the rest of your life. Today, I’ll show you how this new “reduced” form of CoQ10 gives you greater power to prevent and reverse disease. You’ll also discover that it ramps up your energy levels and slows your aging proc...
Source: Al Sears, MD Natural Remedies - January 3, 2018 Category: Complementary Medicine Authors: Francisco Cabrera Tags: Nutrition antioxidants CoQ10 ubiquinol Source Type: news

Supervised balance training and Wii Fit-based exercises lower falls risk in older adults with type 2 diabetes - Morrison S, Simmons R, Colberg SR, Parson HK, Vinik AI.
This study examined the benefits of and differences between 12  weeks of thrice-weekly supervised balance training and an unsupervised at-home balance activity (using the Nintendo Wii Fit) for improving balance and reaction time and lowering fa... (Source: SafetyLit)
Source: SafetyLit - January 3, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Health Highlights: Jan. 3, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Novel Diabetes Drug Battles Alzheimer's in Mice British researchers report that a new kind of type 2 diabetes drug pulled double duty and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2018 Category: General Medicine Source Type: news

Glucagon receptor structure offers new opportunities for type 2 diabetes drug discovery
(Chinese Academy of Sciences Headquarters) Recently, scientists at SIMM determined the crystal structure of GCGR in complex with a glucagon analogue and partial agonist NNC1702. This structure reveals, for the first time, the molecular details of a class B GPCR binding to its peptide ligand at high resolution and unexpectedly discloses the structural complexity that governs receptor activation, thereby greatly expanding the understanding of class B GPCR signal transduction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 3, 2018 Category: International Medicine & Public Health Source Type: news

Scientists Find Possible Alzheimer ’ s Treatment While Trying To Cure Diabetes
CBS Local — Although their goal was to cure diabetes, scientists may have stumbled onto a new medication to help treat the devastating effects of Alzheimer’s disease. According to a press release from researchers at Lancaster University, a new drug being tested for diabetes patients was found to have “significantly reversed memory loss” in test subjects and is now being examined as possible treatment for neurodegenerative disorders. The medication, known as a triple receptor drug — or “triple agonist” — reportedly works in multiple ways to protect the brain aga...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 2, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Alzheimer's Disease Chris Melore degenerative disorders Diabetes Local TV medical treatment talkers Source Type: news

Obesity Is the Main Contributor to Diabetes in Blacks and Whites
Blacks are almost twice as likely to develop Type 2 diabetes as whites. Obesity is the reason, a new study reports. (Source: NYT Health)
Source: NYT Health - January 2, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Diabetes Blacks Race and Ethnicity Obesity Whites Source Type: news

Diabetes drug may be used for treatment of Alzheimer's disease
A drug developed to treat type 2 diabetes " significantly reversed memory loss " in mice that had Alzheimer's disease, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 2, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Alzheimer's: 'Triple-action' diabetes drug shows promise as treatment
A type 2 diabetes drug that activates three growth factor receptors achieved significant reversal of memory loss in a mouse model of Alzheimer's disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 2, 2018 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Gestational diabetes: What are the symptoms and how to test for it
DIABETES is estimated to affect more than five million people in the UK. Type 1 and type 2 diabetes are the two main types but gestational diabetes is another variety. (Source: Daily Express - Health)
Source: Daily Express - Health - January 2, 2018 Category: Consumer Health News Source Type: news

Type 2 diabetes therapy may prevent memory loss
The type 2 diabetes combined therapy of GLP-1, GIP and glucagon was found to protect against neurological degeneration in an Alzheimer’s disease mouse model, according to a study published inBrain Research.Independent (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 2, 2018 Category: Endocrinology Source Type: news

Diabetes drug 'significantly reverses memory loss' in mice with Alzheimer's
A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action. The research, published in Brain Research, could bring substantial improvements in the treatment of Alzheimer's disease through the use of a drug originally created to treat type 2 diabetes. (Source: World Pharma News)
Source: World Pharma News - January 1, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Crash diet found to REVERSE Type 2 diabetes in three months
(Natural News) Type 2 diabetes is one of the greatest health scourges of modern society. The American Diabetes Association reports that close to 10 percent of the American population – or around 30 million people – are currently battling this disease. Diabetes is also one of the leading causes of death, and costs the country... (Source: NaturalNews.com)
Source: NaturalNews.com - December 29, 2017 Category: Consumer Health News Source Type: news

Hypoglycemia Common Among Diabetes Patients in Hospice Care Hypoglycemia Common Among Diabetes Patients in Hospice Care
Hypoglycemia occurs commonly in patients with type 2 diabetes on hospice care in nursing homes, particularly those receiving insulin treatment, new research in JAMA Internal Medicine shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Predicting eGFR Decline and Albuminuria Progression in T2DM Predicting eGFR Decline and Albuminuria Progression in T2DM
Could this newly identified factor help predict diabetic kidney disease progression in type 2 diabetes?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Yes, you can go meatless one day a week
Research consistently shows that plant-based diets are linked with a lower risk of obesity, hypertension, heart disease, type 2 diabetes and cancer. (Source: CNN.com - Health)
Source: CNN.com - Health - December 25, 2017 Category: Consumer Health News Source Type: news

FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes
KENILWORTH, N.J.& NEW YORK--(BUSINESS WIRE) December 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 22, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Steglujan (ertugliflozin and sitagliptin) for Type 2 Diabetes
KENILWORTH, N.J.& NEW YORK--(BUSINESS WIRE) December 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 22, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Steglatro (ertugliflozin) for Type 2 Diabetes
KENILWORTH, N.J.& NEW YORK--(BUSINESS WIRE) December 22, 2017 -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 22, 2017 Category: Drugs & Pharmacology Source Type: news

Early-Onset Type 2 Diabetes'Not a Benign Condition'Early-Onset Type 2 Diabetes'Not a Benign Condition '
Patients who were diagnosed with type 2 diabetes at age 18 to 45 (early-onset) had the highest prevalence of cardiovascular risk factors and worst glycemic control in a Danish national cohort.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Three in 10 Doses of Metformin Not Taken by Patients With T2D Three in 10 Doses of Metformin Not Taken by Patients With T2D
Patients with type 2 diabetes (T2D) are less likely to take the most commonly prescribed diabetes drug, metformin, than other, newer medications, say UK researchers, who suggest adverse events may be to blame.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Pioglitazole linked to lower leptin levels in type 2 diabetes
According to a meta-analysis of RCTs published in theJournal of Diabetes Investigation, pioglitazole use is associated with significantly lower leptin levels in blood.Medical Express (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 22, 2017 Category: Endocrinology Source Type: news

FDA Approves Ertugliflozin for Type 2 Diabetes
The FDA has approved the sodium-glucose cotransporter-2 (SGLT2) inhibitor ertugliflozin as an adjunct to diet and exercise for treating adults with type 2... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 22, 2017 Category: Primary Care Source Type: news